Patents by Inventor John Dixon

John Dixon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MANAGING ACCESS RIGHTS TO CONTENT USING SOCIAL MEDIA
    Publication number: 20190266199
    Abstract: Provided are methods and systems related to communications between a social media service or provider (e.g., Twitter®, Facebook®) or other resource (e.g., web page) and one or more content providers. In an aspect, provided are methods comprising receiving a request for content, wherein the request comprises a user agnostic identifier, determining user information associated with the request, determining time information associated with the request, determining media content associated with the user agnostic identifier based on the time information, determining one or more access rights to the media content based on the user information, and providing access to the media content based on the one or more access rights.
    Type: Application
    Filed: September 26, 2018
    Publication date: August 29, 2019
    Inventors: Christian Petersen, Adam Hertz, John Dixon, Sam Schwartz, Preston Smalley
  • ROTARY VALVE
    Publication number: 20190249799
    Abstract: Rotary valves and methods of using, manufacturing, and storing the same are provided herein. The rotary valve includes a rotor and a stator, biased toward one another to form a fluid tight seal. In some implementations, the rotor comprises an integrated flow channel containing a porous solid support. Frequently, the interface between rotor and stator is made fluid-tight using a gasket. Some implementations of the rotary valve include a displaceable spacer to prevent the gasket from sealing against at least one of the rotor and stator prior to operation, wherein when the spacer is displaced, the gasket seals the rotor and stator together in a fluid-tight manner.
    Type: Application
    Filed: February 15, 2018
    Publication date: August 15, 2019
    Applicant: Talis Biomedical Corporation
    Inventors: Thomas H. Cauley, III, John Dixon
  • Antigen binding proteins that bind c-met
    Patent number: 10377827
    Abstract: There is disclosed compositions and methods relating to or derived from anti-c-Met antibodies. More specifically, there is disclosed fully human antibodies that bind c-Met, c-Met-binding fragments and derivatives of such antibodies, and c-Met-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having c-Met related disorders or conditions, including various inflammatory disorders and various cancers.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: August 13, 2019
    Assignee: SORRENTO THERAPEUTICS, INC.
    Inventors: Barbara A. Swanson, Heyue Zhou, Yan-Liang Zhang, Randy Gastwirt, John Dixon Gray
  • Coumarin derivatives and methods of use in treating hyperproliferative diseases
    Patent number: 10369145
    Abstract: Coumarin derivative compounds and methods for the treatment of hyperproliferative diseases, such as cancer, polycystic kidney disease, and fibrosis of different tissues (e.g., idiopathic pulmonary fibrosis), are provided. The methods include administering to a subject a compound as described herein. Also provided are methods for inhibiting the interaction between two or more heat shock protein chaperones in a cell.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 6, 2019
    Assignee: DISCOVERYBIOMED, INC.
    Inventors: Erik Schwiebert, John Streiff, John Dixon, Hongwu Gao, Joseph P. Ritchie, Eric C. Seales, Deborah Mai
  • COSMETIC COMPOSITIONS FOR COMBATTING COLOUR LOSS FROM A DYED MATERIAL
    Publication number: 20190231664
    Abstract: A concentrate composition comprising: (a) at least 0.1 wt % of a surfactant compound; and (b) at least 10 wt % one or more ingredients selected from aldehydes, succinimidyl esters, chelating agents and amine salts of carboxylic acids.
    Type: Application
    Filed: September 29, 2017
    Publication date: August 1, 2019
    Applicant: INNOSPEC LIMITED
    Inventors: Nicholas John Dixon, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Tony Gough, Ian Malcolm McRobbie
  • ANTIBODY THERAPEUTICS THAT BIND CD137
    Publication number: 20190161554
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD137 antibodies. More specifically, there is disclosed fully human antibodies that bind CD137, CD137-antibody binding fragments and derivatives of such antibodies, and CD137-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression. Diseases amenable to treatment is selected from the group consisting of cancers, autoimmune diseases and viral infections.
    Type: Application
    Filed: February 8, 2019
    Publication date: May 30, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • ANTIBODY THERAPEUTICS THAT BIND CTLA4
    Publication number: 20190127469
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CTLA4 antibodies. More specifically, there is disclosed fully human antibodies that bind CTLA4, CTLA4-antibody binding fragments and derivatives of such antibodies, and CTLA4-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 2, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • Capillary array cartridge for capillary electrophoresis systems
    Patent number: 10274460
    Abstract: The present disclosure relates, in some embodiments, to an apparatus for conducting a capillary electrophoresis assay. The apparatus can comprise a capillary array comprising an anode end and a cathode end, the capillary array provided in a housing further comprising a reservoir configured to house a separation medium and an anode buffer. The system can also comprise an injection mechanism configured to deliver sample to the cathode end of the capillary array, and a temperature control zone, wherein the temperature control zone is configured to control the temperature of the interior of the housing.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: April 30, 2019
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Ian Walton, Achim Karger, Alexander Khorlin, Michael Simon, Adam Sannicandro, Alexander Dukhovny, Robert Cobene, Dan Kline, John Dixon
  • Antibody therapeutics that bind CD137
    Patent number: 10259881
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD137 antibodies. More specifically, there is disclosed fully human antibodies that bind CD137, CD137-antibody binding fragments and derivatives of such antibodies, and CD137-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression. Diseases amenable to treatment is selected from the group consisting of cancers, autoimmune diseases and viral infections.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: April 16, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091120
    Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising an alpha-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: Innospec Limited
    Inventors: Tony Gough, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Nicholas John Dixon, Ian Malcolm McRobbie
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091121
    Abstract: A method of combatting colour loss from a dyed material, the method comprising contacting the material with a composition comprising an alpha-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: Innospec Limited
    Inventors: Nicholas John Dixon, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Tony Gough, Ian Malcolm McRobbie
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091119
    Abstract: A method of combating colour loss from a dyed material, the method comprising contacting the material with a composition comprising a hydroxy-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: INNOSPEC LIMITED
    Inventors: Nicholas John DIXON, Matthew Robert GILES, Kimberley Elizabeth GRIFFITHS, Tony GOUGH, Ian Malcolm MCROBBIE
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190083375
    Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising a hydroxy-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 21, 2019
    Applicant: INNOSPEC LIMITED
    Inventors: Tony GOUGH, Matthew Robert GILES, Kimberley Elizabeth GRIFFITHS, Nicholas John DIXON, Ian Malcolm MCROBBIE
  • Antibody therapeutics that bind CD137
    Patent number: 10233251
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD137 antibodies. More specifically, there is disclosed fully human antibodies that bind CD137, CD137-antibody binding fragments and derivatives of such antibodies, and CD137-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression. Diseases amenable to treatment is selected from the group consisting of cancers, autoimmune diseases and viral infections.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: March 19, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • Antigen Binding Proteins that Bind CCR2
    Publication number: 20190062440
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CCR2 antibodies. More specifically, there is disclosed fully human antibodies that bind CCR2, CCR2-binding fragments and derivatives of such antibodies, and CCR2-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having CCR2 related disorders or conditions.
    Type: Application
    Filed: March 19, 2018
    Publication date: February 28, 2019
    Inventors: Dingqiu Huang, Barbara A. Swanson, John Dixon Gray, Heyue Zhou, Guodi Lu
  • ANTIGEN BINDING PROTEINS THAT BIND PD-L1
    Publication number: 20190060451
    Abstract: There is disclosed compositions and methods relating to or derived from anti-PD-L1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-L1, PD-L1-binding fragments and derivatives of such antibodies, and PD-L1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-L1 related disorders or conditions, including various inflammatory disorders and various cancers.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, Randy Gastwirt, Barbara A. Swanson, John Dixon Gray, Gunnar F. Kaufmann
  • ANTIBODY THERAPEUTICS THAT BIND CD38
    Publication number: 20190048092
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD38 antibodies. More specifically, there is disclosed fully human antibodies that bind CD38, CD38-antibody binding fragments and derivatives of such antibodies, and CD38-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Application
    Filed: August 4, 2018
    Publication date: February 14, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, John Dixon Gray
  • Fully Human Antibodies that Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
    Publication number: 20190048087
    Abstract: There is disclosed compositions and methods relating to anti-VEGFR2 antibodies. More specifically, there is disclosed fully human antibodies that bind VEGFR2, VEGFR2-binding fragments and derivatives of such antibodies, and VEGFR2-binding polypeptides comprising such fragments. Further still, there is disclosed antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having various cancers.
    Type: Application
    Filed: April 7, 2015
    Publication date: February 14, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Randy Gastwirt, Heyue Zhou, John Dixon Gray, Guodi Lu
  • Antibody therapeutics that bind CTLA4
    Patent number: 10202453
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CTLA4 antibodies. More specifically, there is disclosed fully human antibodies that bind CTLA4, CTLA4-antibody binding fragments and derivatives of such antibodies, and CTLA4-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: February 12, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • THERMALLY INKJETTABLE ACRYLIC DIELECTRIC INK FORMULATION AND PROCESS
    Publication number: 20190023914
    Abstract: An aqueous composition for forming a micro-fluid jet printable dielectric film layer, methods for forming dielectric film layers, and dielectric film layers formed by the method. The aqueous composition includes from about 5 to about 20 percent by 65 weight of a polymeric binder emulsion, from about 10 to about 30 percent by weight of a humectant, from about 0 to about 3 percent by weight of a surfactant, and an aqueous carrier fluid. The aqueous composition has a viscosity ranging from about 2 to about 6 centipoise at a temperature of about 23° C.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Applicant: FUNAI ELECTRIC CO., LTD.
    Inventors: Xiaorong Cai, Michael John Dixon, Yimin Guan, Ann P. Holloway, Jeanne Marie Saldanha Singh, Zhigang Xiao